O efeito ansiolítico dos benzodiazepínicos (BZDs) é reduzido depois da primeira exposição ao labirinto em cruz elevado (LCE). Várias hipóteses tem sido formuladas para explicar este fenômeno chamado one-trial tolerance (OTT), entretanto, nenhuma delas é conclusiva. No presente estudo, examinamos este fenômeno através da análise etofarmacológica de ratos submetidos ao LCE em duas sessões (T1 e T2), e do conteúdo de monoaminas presentes no córtex pré-frontal, amígdala, hipocampo e núcleo accumbens através da técnica de Cromatografia Líquida de Alta Pressão. Ratos machos Wistar foram tratados com salina ou midazolam (0,5 mg/Kg, i.p.) antes de T1 e T2 e imediatamente depois, seus encéfalos foram dissecados e as estruturas analisadas. Como controle à análise neuroquímica foram incluídos animais tratados com salina e não expostos ao LCE. A administração de midazolam antes de T1 promoveu efeito ansiolítico, aumentando a exploração dos braços abertos, porcentagem de entradas e tempo de permanência nos mesmos. Em T2 foi observado redução da exploração dos braços abertos em relação a T1. Esses resultados sugerem que há uma mudança no estado emocional do animal em T2, que é resistente a ação ansiolítica dos BZDs. Com relação aos resultados dos estudos neuroquímicos, foi observado redução dos conteúdos de serotonina (5- HT) e noradrenalina (NA) no córtex pré-frontal, na amígdala, no hipocampo e no núcleo accumbens depois de T1 e T2. Houve também, redução do conteúdo de dopamina (DA) na amígdala depois de ambas sessões. Não ocorreram mudanças nas taxas de renovação dessas monoaminas em nenhuma das estruturas analisadas. Através desses resultados, pode-se inferir que a estimulação aversiva do LCE causa alterações na neurotransmissão monoaminérgica da amígdala, como também das outras estruturas límbicas estudadas neste trabalho. Essas alterações neuroquímicas depois da primeira exposição ao LCE, devem representar alterações adaptativas na neurotransmissão do sistema límbico que podem estar associadas ao fenômeno da OTT. / Numerous reports have demonstrated that a single exposure to a variety of stressful experiences enhances fearful reactions when behavior is subsequently tested in current animal models of anxiety. Until now, no study has examined the neurochemical changes during the test and retest sessions of freely-behaving rats in the elevated plus-maze (EPM), one of the most traditional tests of anxiety. This work is a new approach looking at the changes in dopamine (DA), serotonin (5-HT) and noradrenaline (NA) levels in the prefrontal cortex, amygdala, hippocampus and nucleus accumbens during one-trial learning development. We used high pressure liquid chromatography to assess the concentrations of these neurotransmitters and their metabolites in animals injected with saline or midazolam upon single or double exposure to the EPM. For the biochemical analysis an extra control group treated with saline and not exposed to EPM was added. The data showed that stressful stimuli present in the maze were able to elicit one-trial learning to midazolam on re-exposure. Significant decreases in 5-HT and NA contents in the prefrontal cortex, amygdala, hippocampus and nucleus accumbens occurred in saline and midazolam injected animals submitted to the first and second trials. Significant decreases in DA content were also observed in the amygdala after both trials. There was no change in the turnover of these monoamines in any structure studied. It is suggested that aversive stimuli inherent to the EPM cause primary changes in the neurochemical mechanisms of the amygdala and also influence the activity of monoaminergic neurotransmission in the prefrontal cortex, hippocampus and nucleus accumbens. The observed reduction in monoaminergic transmission in limbic structures after the first stressful experience in the EPM seems to represent adaptive changes and may be associated to the phenomenon of ?one-trial tolerance?.

Introdução e objetivos: A dor central pós-acidente vascular cerebral (DCAVC) é causada pela lesão vascular de estruturas somatossensitivas encefálicas e comumente refratária aos tratamentos farmacológicos disponíveis atualmente. A estimulação magnética transcraniana repetitiva (EMTr) do córtex pré-frontal dorsolateral (CPFDL) pode alterar o limiar da dor térmica de indivíduos saudáveis e exercer efeito analgésico na dor aguda pós-operatória e em doentes com síndrome fibromiálgica. No entanto, seu efeito na dor neuropática e na DCAVC, em particular, ainda não foi avaliado. O objetivo do presente estudo, delineado de modo prospectivo, duplamente encoberto e controlado com placebo foi o de se avaliar o efeito analgésico da EMTr do CPFDL em doentes com DCAVC. Casuística e métodos: 21 doentes foram incluídos aleatoriamente em dois grupos, os do grupo ativo (EMTr-A) e os do grupo placebo (EMTr-S) e tratados, respectivamente, com dez sessões diárias de EMTr verdadeira (EMTr-A) ou sham (EMTr-S) do CFPDL esquerdo (10 Hz, 1250 pulsos/dia). A Escala Visual Analógica (EVA), o Questionário de Dor Neuropática e o Questionário de Dor McGill foram utilizados para avaliar-se a DCAVC. A depressão, a ansiedade e a qualidade de vida foram avaliadas, respectivamente, com a Escala de Hamilton para Depressão, Escala de Hamilton para Ansiedade e o Short Form Health Survey com 36 itens. As avaliações foram realizadas antes do início do estudo, durante a fase de estimulação e uma, duas e quatro semanas após a aplicação da última sessão de EMTr-A ou EMTr-S. O desfecho principal foi a alteração da intensidade da dor medida no último dia de estimulação em relação à intensidade do seu valor basal de acordo com a EVA. Foi programada uma análise interina dos resultados ao término da avaliação da metade dos doentes programados de acordo com o protocolo de tratamento. Resultados: Os escores médios basais da EVA foram 6,86 (+/- 1,79) e 6,8 (+/- 2,20) para os doentes dos grupos EMTr-A e EMTr-S, respectivamente; a variação média da EVA após o décimo dia de estimulação foi de - 0,07 (+/- 0,24) para os doentes do grupo EMTr-A e 0,1 (+/- 0,7) para o os do grupo EMTr-S. O tamanho do efeito do tratamento foi 0,02 (d de Cohen= 0,04). O estudo foi encerrado devido à significativa falta de eficácia da EMTr-A. Conclusão: A EMTr do CPFDL esquerdo não proporcionou efeito analgésico em doentes com DCAVC / Introduction and objectives: Central post-stroke pain (CPSP) is caused by an encephalic vascular lesion of the somatosensory pathways and is refractory to current pharmacological treatments. Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex (DLPFC) can change thermal pain threshold and cause analgesia in healthy subjects and also in acute post operatory pain as well as in fibromyalgia patients. However, its effect on neuropathic pain and particularly in CPSP patients has not been assessed yet. The aim of this prospective, double blind, shamcontrolled study was to evaluate the analgesic effect of left DLPFC rTMS in CPSP patients. Patients and methods: 21 patients were randomly included in two groups: the active (A-rTMS) group and the placebo (S-rTMS) group and were treated, respectively, with 10 daily sessions of real rTMS (A-rTMS) or sham (S-rTMS) of the left DLPFC (10 Hz, 1250 pulses/day). Visual Analogue Scale (VAS), Neuropathic Pain Questionnaire and McGill Pain Questionnaire were used to evaluate the CPSP. The depression, the anxiety and the quality of life were evaluated, respectively, with the Hamilton Scale for Depression, Hamilton Scale for anxiety and the Short Form Health Survey with 36 items. Outcomes were assessed at the baseline, during the stimulation phase and at one, two and four weeks after the last session of ArTMS or S-rTMS. The main outcome was pain intensity change measured with the VAS at the last session of A-rTMS or S-rTMS, compared to the baseline. Interim analysis was scheduled when the first half of the patients have completed the study. Results: The average baseline scores of VAS were 6.86 (+/- 1.79) and 6.8 (+/- 2.20), respectively, for the groups A-rTMS and S-rTMS. The average variation of VAS after the 10th stimulation session was - 0.07 (+/- 0.24) for A-rTMS and 0.1 (+/- 0.7) to the S-rTMS group and the effect size of A-EMTr was 0.02 (Cohen\'s d= 0.04). The study was discontinued due to the significant lack of efficacy of the A-rTMS. Conclusion: Repetitive transcranial magnetic stimulation of the left DLPFC did not provide an analgesic effect in CPSP patients

O núcleo talâmico mediodorsal (Tmd) e o córtex pré-frontal (CPF) comunicam-se mutuamente, formando um circuito envolvido em funções executivas e transtornos psiquiátricos. As funções executivas estão sujeitas aos níveis de alerta gerados pela atividade oscilatória talamocortical, que por sua vez é controlada pela transmissão colinérgica. Possivelmente, a plasticidade sináptica do circuito Tmd-CPF é sensível tanto aos padrões oscilatórios do próprio circuito quanto à modulação colinérgica. Porém, esta possibilidade ainda não foi testada, muito menos dissociando-se a participação dos receptores muscarínicos e nicotínicos. Assim, nosso objetivo foi examinar como a plasticidade Tmd-CPF é modulada sob estados oscilatórios globais mediados pelo sistema colinérgico, e se esta modulação varia com os tipos de receptores recrutados. Anestesiamos ratos com uretana e implantamos um eletrodo de estimulação no Tmd, um eletrodo de registro no CPF e uma cânula de microinjeção acima do ventrículo. Emitimos 90 pulsos elétricos no Tmd (0,05 Hz) para evocação de potenciais pós-sinápticos de campo (PPSCs) basais no CPF por 30 min. Em seguida, aplicamos injeção intraventricular do agonista muscarínico pilocarpina (PILO), do agonista nicotínico nicotina (NIC), ou veículo-controle (VEIC). Os efeitos das substâncias sobre potenciais de campo locais (eletrencefalograma) foram monitorados através dos mesmos eletrodos. PILO e NIC induziram aumento das oscilações rápidas (4-80 Hz) e proporcional redução das oscilações lentas mantidas pela anestesia (0,5-4 Hz) e tais efeitos duraram ~10-15 min, conforme padronização prévia das concentrações das drogas. Justamente durante este período, aplicamos estimulação em alta frequência (EAF) ou baixa frequência (EBF) para indução de, respectivamente, potencialização (PLD) ou depressão (DLD) de longa duração, que são modelos bem conhecidos de plasticidade sináptica. Em grupos-controle, a injeção de PILO, NIC ou VEIC foi desacompanhada de EAF/EBF. Por fim, retomamos a coleta de PPSCs a 0,05 Hz por 240 min. Os resultados mostraram que a EAF não afetou os PPSCs quando aplicada após VEIC. Porém, nos ratos PILO e NIC, os PPSCs tiveram amplitude aumentada a partir de 150 min após EAF, indicando que a pré-ativação colinérgica foi necessária à indução de uma PLD tardia. Inversamente, quando a EBF foi aplicada após VEIC, a amplitude dos PPSCs foi reduzida de modo estável por 240 min. Isto não ocorreu quando a EBF foi aplicada após PILO e NIC, sugerindo que a modulação colinérgica suprimiu a DLD. Nos grupos-controle, PILO, NIC e VEIC sozinhos não afetaram os PPSCs em longo prazo, confirmando que os resultados de PLD e DLD são devidos a uma interação entre a pré-ativação colinérgica e mecanismos sinápticos desencadeados pela EAF/EBF.Portanto,as oscilações rápidas induzidas pela transmissão colinérgica favorecem a PLD no circuito Tmd-CPF, enquanto dificultam sua DLD. Além disto, os efeitos muscarínicos e nicotínicos sobre a plasticidade de longo prazo são iguais, apesar de os mecanismos celulares destes receptores serem diferentes. Nossos achados ajudam a esclarecer a regulação do sinal talâmico no CPF sob modulação colinérgica fisiológica (atenção e sono paradoxal) e disfuncional (esquizofrenias e doença de Alzheimer). / The mediodorsal thalamic nucleus (MD) and the prefrontal cortex (PFC) communicate with each other, constituting a circuit involved in executive functions and psychiatric disorders. Executive functions are subject to arousal levels driven& by the thalamocortical oscillatory activity, which in turn is controlled by the cholinergic neurotransmission. Possibly, the MD-PFC synaptic plasticity is susceptible to both the oscillatory patterns within the MD-PFC circuit and the cholinergic modulation. However, this likelihood is still untested, as well as the specific roles of muscarinic and nicotinic receptors. Thus, our aim was to evaluate whether and how the MD-PFC plasticity is modulated under cholinergic system-dependent oscillatory states of the forebrain, and if such modulation varies with the subtypes of activated cholinergic receptors. For that, we anesthetized rats with urethane to implant a stimulating electrode into the MD, a recording electrode into the PFC, and a microinjection cannula above the ventricle. We applied 90 monophasic square pulses into the MD (0.05 Hz) for recording of basal field postsynaptic potentials (fPSPs) in the PFC for 30 min. Then, we did an intraventricular injection of either the muscarinic agonist pilocarpine (PILO), the nicotinic agonist nicotine (NIC), or a control vehicle (Veh). The drug effects on local field potentials (electroencephalogram) were monitored through the same electrodes. PILO and NIC induced an increase in theta, beta and gamma oscillations (4-80 Hz) with proportional reduction of urethane-driven delta waves (0.5-4 Hz), and these effects survived approximately 10-15 min according to pilot-experiments on PILO and NIC concentrations. During this period, we applied either high-frequency (HFS) or low-frequency stimulation (LFS) for induction of respectively long-term potentiation (LTP) or depression (LTD), which are well-known synaptic plasticity models. In control groups, the injection of PILO, NIC or Veh was not followed by the HFS/LFS. Lastly, we resumed the evoking of fPSP at 0.05 Hz for an additional 240 min. The results showed that the HFS did not affect the fPSPs when applied after the Veh. However, in PILO and NIC rats the fPSP had their amplitudes increased from 150 min after HFS, indicating that the cholinergic pre-activation was required for the induction of a late-phase LTP. On the other hand, when the LFS was applied after the Veh, the fPSP amplitudes were stably decreased for 240 min, which did not occur when the LFS was applied after PILO and NIC, suggesting that the cholinergic modulation suppressed the LTD. In the control groups, PILO, NIC, and Veh by themselves did not change fPSPs in the long term, reinforcing that the LTP and LTD were due to an interaction between the cholinergic pre-activation and synaptic mechanisms triggered by the HFS/LFS. Therefore, the rapid oscillations induced by the cholinergic transmission favor LTP in the MD-PFC loop, while occlude its LTD. Moreover, the muscarinic and nicotinic effects on long-term plasticity were equal, although their quite distinct cell mechanisms. Our findings might help clarify the regulation of thalamic signals on the PFC both under physiological (attention and rapid-eye-movement sleep) and dysfunctional (schizophrenia symptoms and Alzheimer\'s) cholinergic drive.

La consommation de cannabis chez les adolescents et les jeunes adultes constitue un facteur de risque de développement de symptômes psychotiques. L’objectif de cette thèse était d’étudier les conséquences à l’âge adulte d’une exposition chronique aux cannabinoïdes pendant l’adolescence. Nous avons réalisé ces études chez le Rat et démontré que l’administration chronique d’un agoniste des récepteurs cannabinoïdes, le CP55, 940, durant l’adolescence (JPN 29 à 50) entraîne à l’âge adulte des déficits significatifs et durables de la mémoire à court terme et de la mémoire de travail spatiale. Le même traitement administré à l’âge adulte (JPN 70 à 91) n’entraîne pas de déficits cognitifs à long terme. L’apport de ces travaux et leur originalité a été de contribuer à la compréhension des mécanismes sous-jacents au développement de ces déficits cognitifs. Nous avons mis en évidence, chez ces rats à l’âge adulte, une diminution significative de l’amplitude de la PLT induite sur le circuit reliant l’hippocampe au cortex préfrontal, fortement impliqué dans les processus de mémoire et dans la physiopathologie de la schizophrénie. Ce déficit de PLT a été mis en relation avec des modifications de la morphologie des neurones pyramidaux de la couche II/III du cortex préfrontal et de certains marqueurs de la plasticité synaptique. Ces résultats confirment que l'adolescence est une période critique et vulnérable aux effets délétères des cannabinoïdes sur les processus cognitifs. L’étude des bases neurobiologiques de ces effets, en particulier en ce qui concerne les altérations des circuits préfrontaux, devrait améliorer notre compréhension des mécanismes de l'émergence de la psychose et conduire à de nouvelles stratégies thérapeutiques et de prévention. / Cannabis use among adolescents and young adults is a risk factor for developing psychotic symptoms. The aim of this thesis was to study the consequences at different levels (behavioral, functional and structural in adulthood) of chronic exposure to synthetic cannabinoids during adolescence in the rat. We showed that chronic administration of a cannabinoid receptor agonist, CP 55940, during adolescence (PND 29-50) in rats leads to significant long-term deleterious effects in short-term memory and in spatial working memory in adulthood. The same treatment administered in adulthood (PND 70-91) does not cause long-term cognitive deficits. We further demonstrated that cannabinoid during adolescence leads in adults to a significant decrease in the expression of LTP induced in hippocampal to prefrontal cortex synapses, a circuit directly involved in memory processes and in the pathophysiology of schizophrenia. This alteration could be associated with changes in the morphology of pyramidal neurons in layer II / III of PFC and/or in the density of synaptic markers that we also identified in these cannabinoid-treated rats. These findings demonstrate that adolescence is a critical and vulnerable period to the deleterious effects of cannabinoids on cognitive processes. The neurobiological basis for this effect, especially with regard to alterations to prefrontal circuitry, which we partially provide should improve our understanding of the emergence of psychosis and lead to new therapeutic strategies and prevention.

Cette thèse avait pour objectif d’étudier le rôle du circuit composé de l’hippocampe (Hip), du cortex préfrontal médian (mPFC) et des noyaux reuniens et rhomboïde (ReRh) du thalamus dans les processus cognitifs qui sous-tendent la mémoire spatiale chez le Rat. Nous avons montré que les noyaux ReRh pourraient être impliqués dans la consolidation systémique, mécanisme nécessaire à la persistance des souvenirs et nécessitant un dialogue hippocampo-cortical. Nous avons mis en évidence que l’activité neuronale du mPFC durant le rappel d’une mémoire ancienne dépend des noyaux ReRh, ainsi que l’implication de ces noyaux dans une tâche de mémoire spatiale (dépendante de l’Hip) nécessitant une flexibilité comportementale (impliquant le mPFC). Enfin, nous avons montré un rôle du mPFC dans le rappel d’une mémoire spatiale récente. Ces résultats mettent en évidence l’importance de ce circuit hippocampo-cortico-thalamique dans le traitement et la persistance des informations spatiales chez le Rat. / This thesis aimed to investigate the role of a circuit encompassing the hippocampus (Hip), the medial prefrontal cortex (mPFC) and the reuniens and rhomboid nuclei (ReRh) of the thalamus in cognitive processes underlying spatial memory in rats. We first showed that ReRh nuclei may be involved in systemic consolidation, a mechanism necessary for memory persistence and requiring hippocampal-cortical interactions. We confirmed these findings in a second study showing that mPFC neuronal activity during recall of a remote spatial memory depends on ReRh thalamic nuclei. We also showed the involvement of the ReRh nuclei in a mnemonic task requiring the use of both spatial information (dependent on the Hip) and behavioral flexibility (involving the mPFC). Finally, we found a role of the mPFC in the recall of recent spatial memory. Taken together, these results highlight the importance of a hippocampo-cortico-thalamic circuit in the processing and persistence of spatial information in the Rat.

La plasticité cérébrale pathologique qui se met en place en réponse à l'administration répétée de drogue nécessite des modifications de l’expression des gènes, au moyen,entre autres, de mécanismes épigénétiques tels que la méthylation de l’ADN. Dans ces travaux, nous avons montré que l’inhibition des ADN méthyl transférases par la 5-aza-2’-désoxycytidine augmentait les propriétés renforçantes de la cocaïne dans un protocole d’auto-administration intraveineuse, et ce, sans affecter la motivation des rats pour la cocaïne, ni la réactivation du comportement de recherche après une période de sevrage.L’analyse du méthylome dans le cortex préfrontal médian nous a permis de caractériser près de 190000 régions génomiques différentiellement méthylées suite au traitement par la cocaïne, en association ou non avec la 5-aza-2’-désoxycytidine. Nous avons sélectionné une vingtaine de régions situées soit dans les promoteurs soit au sein de gènes participant à la plasticité neuronale. L’analyse de la transcription de ces gènes a permis, pour certains d’entre eux, de corréler les variations de méthylation avec celles d’expression, comme dans le cas du gène Hdac2. / Repeated drug administration lead to pathological brain plasticity that requires modifications of gene expression through, among others, epigenetic mechanisms such DNA methylation. Here, we showed that DNA methyltransferases inhibitors such 5-aza-2’-deoxycytidine increase reinforcing properties of cocaine in an intravenous self administration paradigm without affecting the motivation of rats for the drug, nor drug seeking after withdrawal. The analysis of the methylome in the medial prefrontal cortex allowed us to identify approximatively 190000 differentially methylated genomic regions in response to cocaine treatment, in association or not with 5-aza-2’-deoxycytidine. We selected around twenty regions within promoters or body of genes known to participate in neuronal plasticity. The study of the transcription of these genes permitted for some of them to correlate the modifications of the DNA methylation with the modifications of the expression, like, for example, in the case of the gene Hdac2.

La capacité des organismes à survivre dans un environnement changeant dépendlargement de leur aptitude à prendre des décisions adaptées. Cette fonction complexerésulte notamment de l’intégration de processus de prédiction et de contrôle de l’action,classiquement étudiés dans le corpus théorique et méthodologique des apprentissagesassociatifs. Les bases neurobiologiques de ces processus sont largement distribués au seinde circuits au sein desquels le cortex préfrontal et son afférence principale, le thalamusmédiodorsal (MD) jouent un rôle important. Dans ce contexte, le travail entrepris au coursde ce travail de thèse visait à déterminer le rôle fonctionnel des échanges entre ces deuxstructures dans le cadre de la prise de décision.Une première partie de ce travail a visé à confirmer le rôle spécifique du MD dans lesprocessus de prise de décision. Par l’utilisation d’un protocole expérimental nécessitantl’intégration des contingences instrumentales et Pavloviennes pour obtenir unerécompense, nous avons démontré que des rats porteurs d’une lésion du MD n’étaient pascapables d’adapter leur comportement en fonction des changements de valeur de larécompense, confirmant ainsi le rôle fondamental du MD dans la représentation du but.Surla base de ce résultat, nous avons ensuite entrepris une étude d’anatomie descriptive visantà caractériser finement l’architecture des projections thalamocorticales issues du MD. Cetteétude nous a permis de démontrer que de multiples voies thalamocorticales issues du MDtrouvent leur origine dans des populations neuronales thalamiques essentiellementségrégées mais également que la région orbitofrontale était innervée par une régionthalamique méconnue, le thalamus submédian. Pour éprouver les fonctions de cesdifférentes voies, nous avons d’abord mis en place une stratégie d’inactivation réversible depopulations neuronales sélectionnées sur la base de leurs projections spécifiques par uneméthode pharmacogénétique conditionnelle. L’utilisation de cette méthode nous a permisde révéler que la capacité de l’animal à se représenter la valeur ou la relation actionrécompensedépend de la direction des échanges entre le MD et le cortex préfrontalmédian. Par ailleurs, une approche lésionnelle comparée plus classique nous a permisd’identifier un rôle fonctionnel spécifique du thalamus submédian dans la mise à jour descontingences Pavloviennes.12Pris dans leur ensemble, ces résultats sont en accord avec l’idée que des bouclesthalamocorticales distinctes sont impliquées dans les processus de prédiction et de contrôlede l’action nécessaires à une prise de décision adaptée. / Survival of living organisms depends on the ability to make decision adapted to theircurrent needs and desires. Such an ability results from the integration of multiple basiccognitive processes such as events prediction and action control. These processes are bestinvestigated within the framework of associative learning. Past research has demonstratedthat these processes are supported by a widespread neuronal circuit, in which the prefrontalcortex and his major afferent structure, the mediodorsal thalamus (MD), play a central role.In this context, this thesis work aimed at investigating the functional role of the exchangesbetween these two structures in decision making.In a first part of this work, we assessed the role of the MD in prediction and control.We showed that MD lesioned rats are unable to adapt their behavior to a change in rewardvalue, in an experimental procedure asking the integration of instrumental and Pavloviancontingencies. This result confirmed the fundamental role of MD in goal representation. As asecond step, we performed an anatomical study in order to characterize the architecture ofthe thalamocortical pathways arising from the MD. We first showed that multiplethalamocortical pathways originate from segregated neuronal populations within the MD.We also discovered a poorly known thalamic structure innervating the orbitofrontal cortex,the submedius nuclei. In order to understand the functional role of these pathways, we useda conditional chemogenetic technique aimed at inactivating neuronal populations selectedon the basis of their projections. Using this technique, we showed that the animal’s abilitiesto represent either the value or the action-reward relationship depend on the directionalityof MD and prefrontal cortex exchanges. Finally, we identified a specific role for thesubmedius nuclei in updating Pavlovian contingencies, by using a more classical lesioningapproach.Taken together, these results support the idea that decision making involved severalthalamocortical loops, differentially supporting prediction and action control.

Bien que la neurotransmission glutamatergique joue un rôle pivot dans le développement et l’expression de la sensibilisation comportementale aux amphétamines, le rôle spécifique de certaines structures glutamatergiques qui projettent sur l’aire tegmentale ventrale et/ou le noyau accumbens n’est pas encore bien caractérisé. Nous montrons que l’hippocampe dorsal, la partie prélimbique du cortex préfrontal et l’amygdale basolatérale joue un rôle prépondérant dans les réponses locomotrices induites par l’administration aiguë (développement de la sensibilisation) et chronique (expression de la sensibilisation) d’amphétamines, suggérant les réponses locomotrices aux amphétamines impliquent un ensemble de structures glutamatergiques corticolimbiques. Par la suite, nous nous sommes intéressés au rôle de la neurotransmission glutamatergique associée aux récepteurs NMDA dans le noyau accumbens, qui est considéré comme le noyau clé de l’expression de la sensibilisation, sur le développement à court terme de la sensibilisation aux amphétamines. De plus, nous montrons le développement de la sensibilisation à court terme aux amphétamines requiert l’activation concomitante de certains récepteurs NMDA au glutamate et nicotiniques à l’acétylcholine dans le noyau accumbens. De plus, l’activation concomitante de ces récepteurs sous tend également la libération de dopamine induite par les amphétamines dans le noyau accumbens. L’ensemble de ces données montre que la neurotransmission glutamatergique, et les structures glutamatergiques qui projettent sur l’aire tegmentale ventrale et/ou le noyau accumbens, joue un rôle majeur dans la sensibilisation comportementale à court terme aux amphétamines. / Although it is well admitted that the glutamatergic neurotransmission plays a pivotal role in the development and expression of behavioral sensitization to amphetamine, the specific role of glutamatergic structures that project to the ventral tegmental and/or the nucleus accumbens is less well studied. We showed that the dorsal hippocampus, the prelimbic part of the prefrontal cortex and the basolateral amygdala play a critical role in both acute (development of sensitization) and chronic (expression of sensitization) locomotor responses induced by amphetamine, suggesting that behavioral responses to amphetamine are mediated by circuitry of corticolimbic glutamatergic structures. Next, we investigated the role of glutamatergic NMDA receptors contained in the nucleus accumbens, which is seen as the key structure for the expression of sensitization, in the development of short term sensitization to amphetamine. Interestingly, we showed that, contrasting with the current dichotomous thinking that has attributed specialized functions to the ventral tegmental area and the nucleus accumbens, respectively in the development and the expression of behavioral sensitization, concomitant activation of certain types of NMDA and nicotinic receptors in the nucleus accumbens is also required for the development of short term sensitization. Furthermore, we showed that concomitant activation of these receptors sustained the amphetamine-induced dopamine release in the nucleus accumbens. All these data show that glutamatergic neurotransmission, and glutamatergic structures which project onto mésoaccumbens system, plays a major role in short-term behavioral sensitization to amphetamine.

La perception menant à une prise de décision implique de multiples aires corticales. Il a été proposé que l'information sensorielle se propage des aires sensorielles primaires, codant principalement la nature du stimulus, aux aires de haut-niveau - plus frontales - codant d'avantage la valence du stimulus ou la décision. Pour mieux comprendre l'intégration corticale des signaux sensoriels, nous avons enregistré les réponses sensorielles évoquées (RSE) simultanément dans différentes aires corticales, tandis que des souris apprenaient une tâche de détection sensorielle. Chez les souris ayant appris la tâche, une RSE est observée dans toutes les aires enregistrées suivant la stimulation de la vibrisse, avec des latences croissantes des aires somatosensorielles primaire (vS1) et secondaire (vS2), vers le cortex moteur primaire des vibrisses (vM1), le cortex pariétal associatif (PtA), l'hippocampe dorsal (dCA1) et enfin le cortex préfrontal médian (mPFC). Nous avons constaté une réduction des RSEs lors des échecs par rapport aux essais réussis dans toutes les aires, sauf vS1. Toutefois, seule l'inactivation de vS1, vS2 ou mPFC affecte significativement la performance des souris. Pendant l'apprentissage de la tâche, une augmentation sélective de la RSE est observée dans le mPFC en corrélation avec la performance. Des enregistrements unitaires dans le mPFC démontrent la nature excitatrice de la réponse sensorielle chez les souris entrainées. Nos résultats confirment ainsi que la réponse sensorielle dans le mPFC reflète l'importance comportementale du stimulus et corrèle avec la prise de décision, tandis que la réponse des aires sensorielles reflète plutôt la nature du stimulus / Sensory perception leading to goal-directed behavior involves multiple, spatially-distributed cortical areas. It has been hypothesized that sensory information flows from primary sensory areas encoding mainly the nature of the stimulus, to higher-order, more frontal, areas encoding the valence of the stimulus or the decision. To further understand the cortical integration of sensory signals, we recorded sensory evoked potentials (SEPs) simultaneously from different areas while mice learned a whisker-based sensory detection task. In mice that have learned the task, the whisker stimulus evoked SEP in all recorded areas with latencies increasing from the whisker primary (wS1) to the secondary somatosensory area (wS2), the whisker motor area (wM1), the parietal area (PtA), the dorsal hippocampus (dCA1) and the medial prefrontal cortex (mPFC). We found a reduction of SEPs during Miss trials compared with Hit trials in all areas except wS1. However, only the local inactivation of either wS1, wS2 or mPFC significantly impaired the mice performance. During training to the detection task, we observed a selective increase of the SEPs in mPFC that correlated with performance. Finally, using high-density extracellular recordings in mPFC, we found that whisker stimulation in trained mice evoked an early increase in the firing rate of putative excitatory neurons (regular spiking units) that was positively correlated with behavioral outcome. Our results support the idea that mPFC could signal the relevance of a sensory stimulus in the context of a well-defined behavior, whereas sensory areas would be more constrained by the nature of the stimulus

Choisir entre l'action ou l'inaction est peut-être le type de décision le plus critique auquel un animal peut faire face. Une formalisation simple de ces choix consiste à évaluer les bénéfices attendus (nourriture, argent par exemple) ainsi que les coûts (punitions, pertes de temps ou d'argent) associés à chaque action et d'optimiser le rapport entre récompenses reçues et coûts assumés. Notre motivation à s'engager dans une action donnée dépend donc de la valeur de ce rapport. Dans le domaine de l'économie comportementale, l’optimisation de ce rapport bénéfices/coûts constitue le principe fondamental qui régule et explique le comportement des individus. Dans mes travaux de thèse, j'ai réalisé une implémentation de ces concepts venant de l'économie comportementale en utilisant une forme expérimentalement quantifiable de coûts: l'effort physique. Dans notre vie de tous les jours, si l'on nous demande de choisir entre deux options rapportant les même bénéfices mais demandant différents efforts (par exemple, travailler 3 ou 7 jours par semaine pour le même salaire), nous choisissons habituellement l'option qui nécessite la plus petite dépense d'énergie, en optant donc pour le moindre effort. Néanmoins, l'effort physique a été beaucoup moins étudié en comparaison à d'autres formes de coûts comme le fait de différer la récompense ou d'en augmenter l'incertitude. Le présent travail de recherche a donc pour but de mettre en lumière les bases neurales de la balance récompense / effort dans la prise de décision. Comprendre comment l'effort affecte la dévaluation des potentielles récompenses a un intérêt particulier pour la prise de décisions économiques mais aussi pour la clinique, étant donné que la diminution de la capacité à accepter d'avoir à exercer un effort est un symptôme-clé de nombreuses pathologies comme l'apathie ou la dépression. Nous faisons l’hypothèse que de tels désordres pourraient résulter de deux différents processus comportementaux: (a) une diminution de la sensibilité aux bénéfices futurs et/ou (b) une sensibilité excessive aux coûts potentiels. Ainsi, lorsqu'interrogés sur les raisons pour lesquelles ils ne veulent pas aller au cinéma regarder un film qu'ils apprécient, les patients apathiques peuvent déclarer que (a) le film n'est pas assez bon (soit une plus faible réponse à la valeur attendue), (b) le cinéma est trop loin (soit une plus forte sensibilité à l'effort anticipé). Afin de tester ces hypothèses, nous avons enregistré l'activité de neurones chez le singe pendant des tâches comportementales. Nous avons trouvé que d'une part, la dopamine encode la valeur de l'action future et oriente le comportement vers l'option demandant le moindre effort. D'autre part, la noradrénaline permet à l'individu de faire face à l'effort à venir en réduisant la sensibilité à l'anticipation de l'effort. En utilisant une approche pharmacologique, nous avons démontré que lorsque le niveau de noradrénaline est augmenté, les singes exercent d'avantage d'effort. En outre, nous avons montré que les potentiels locaux de champ dans le cortex pré-frontal ventro-médian, enregistrés dans une tâche comportementale identique, sont modulés par la valeur attendue et prédisent le choix du singe. En résumé, ce travail permet de départager en partie les circuits neuronaux impliqués dans le calcul de la balance récompense / effort, principalement encodée par les neurones dopaminergiques et dans les potentiels locaux de champ au niveau du cortex pré-frontal ventro-médian. Enfin, ce travail souligne le rôle de la noradrénaline dans la mobilisation de l'énergie d'un individu afin de faire face au défi que représente l'effort physique. / There is perhaps no more critical factor for the behaviour of an animal than the way it chooses between action and inaction. A simple way to formalise such choices is to evaluate the predicted benefit (e.g. food, money) and costs (e.g. punishments, losses, delays) associated with each action and optimise the rates at which rewards are received and costs avoided. Our motivation to perform a given action depends upon such value ratio. In the current behavioural economics literature, the optimisation of the benefits/costs ratio stands as the fundamental principle that regulates and explains agents’ behaviour. In my Ph.D. studies, I implement a realistic model of such concepts from behavioural economics by using an empirical type of cost: physical effort. In our everyday life, if we are asked to choose between two options that imply the same reward but different efforts (e.g., working 3 or 7 days per week for the same salary), we usually opt for the alternative that requires the slightest energy expenditure, thus the least effort. However, physical effort has been far less studied compared to other decision costs such as delay or uncertainty. The present Ph.D. work aims at highlighting the neuronal bases of such reward/effort tradeoff. Understanding how effort cost affects the discounting of potential rewards has a clear significance for economic decisions and clinics, since the reduced willingness to exert effort is a key signature of several clinical disorders such as apathy and depression We suggest that disorders such as apathy could result from two different behavioural processes: (a) a decreased responsiveness to future benefits and/or (b) an excessive sensitivity to potential costs. For instance, when asked why they would not go see a movie they like, patients may say that (a) the movie is not good enough (i.e. low responsiveness to expected value) or that (b) the theatre is too far away (i.e. high sensitivity to anticipated effort). To test our hypothesis, we combined behavioural tasks and pharmacological approach with neuron recordings in monkeys, targeting specifically two majors actors of the rewarding and effort system, dopamine and noradrenaline. We found that dopamine and noradrenaline have distinct but complementary roles. On the one hand, dopamine tracks the reward value of future outcomes and orient the behaviour towards the least effortful options. On the other hand, noradrenaline enables subjects to face the effort at hand, reducing the sensitivity to anticipated effort. Using a pharmacological approach, we found that, when we increase noradrenaline, monkeys exerted significantly more effort. Moreover, we have found that local field potentials in the ventromedial prefrontal cortex recorded in the same task encode the expected value and predict action selection. In summary, this Ph.D. work allows to disentangle some of the neuronal circuits implicated in the computation of the reward/effort tradeoff, mainly encoded by dopaminergic neurons and in the local field potential of the ventromedial prefrontal cortex. On the other hand, this work highlights the role of noradrenaline in the energization of behaviour to face the challenge represented by the physical effort.